z-logo
open-access-imgOpen Access
Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer
Author(s) -
Zuen Ren,
Huizhi Liang,
Phillip M. Galbo,
Malindrie Dharmaratne,
Ameya Kulkarni,
Atefeh Taherian Fard,
Marie Louise Aoun,
Nuria Martínez-López,
Kimita Suyama,
Outhiriaradjou Benard,
Wei Zheng,
Yang Liu,
Joseph Albanese,
Deyou Zheng,
Jessica C. Mar,
Rajat Singh,
Michael B. Prystowsky,
Larry Norton,
Rachel B. Hazan
Publication year - 2022
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2107266119
Subject(s) - biology , angiogenesis , cancer research , warburg effect , glycolysis , endocrinology , metabolism
Significance Redox regulation of breast cancer underlies malignant progression. Loss of the antioxidant glutathione peroxidase 2 in breast cancer cells increases reactive oxygen species, thereby activating hypoxia inducible factor-α (HIF1α) signaling. This in turn causes vascular malfunction, resulting in hypoxia and metabolic heterogeneity. HIF1α suppresses oxidative phosphorylation and stimulates glycolysis (the Warburg effect) in most of the tumor, except for one cancer subpopulation, which was capable of using both metabolic modalities. Hence, adopting a hybrid metabolic state may allow tumor cells to survive under aerobic or hypoxic conditions, a vulnerability that may be exploited for therapeutic targeting by either metabolic or redox-based strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom